These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28991523)

  • 1. The LSS Cohort of Atomic Bomb Survivors and LNT. Comments on ''Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009" (Radiat Res 2017; 187:513-37) and "Reply to the Comments by Mortazavi and Doss" (Radiat Res 2017; 188:369-71).
    Siegel JA; Sacks B; Socol Y
    Radiat Res; 2017 Oct; 188(4):463-464. PubMed ID: 28991523
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to the Comments by Mortazavi and Doss on "Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009" (Radiat Res 2017; 187:513-537).
    Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
    Radiat Res; 2017 Sep; 188(3):370-371. PubMed ID: 28891739
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on "Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009" (Radiat Res 2017; 187:513-537).
    Mortazavi SMJ; Mohan D
    Radiat Res; 2017 Sep; 188(3):369-371. PubMed ID: 28632433
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors by Cologne
    Walsh L; Schneider U
    Radiat Res; 2020 Feb; 193(2):195-197. PubMed ID: 31794333
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on "Studies of the mortality of atomic bomb survivors, report 14, 1950-2003: an overview of cancer and noncancer diseases" (Radiat Res 2012; 177:229-43).
    Doss M; Egleston BL; Litwin S
    Radiat Res; 2012 Sep; 178(3):244-5. PubMed ID: 22817395
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation and cancer risk in atomic-bomb survivors.
    Kodama K; Ozasa K; Okubo T
    J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on the article "Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990" by D. A. Pierce, Y. Shimizu. D. L. Preston, M. Vaeth and K. Mabuchi (Radiat. Res. 146, 1-27, 1996).
    Little MP
    Radiat Res; 1997 Oct; 148(4):399-401. PubMed ID: 9339957
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term epidemiological studies of atomic bomb survivors in Hiroshima and Nagasaki: study populations, dosimetry and summary of health effects.
    Okubo T
    Radiat Prot Dosimetry; 2012 Oct; 151(4):671-3. PubMed ID: 22908354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation effects on cancer risks in the Life Span Study cohort.
    Kodama K; Ozasa K; Katayama H; Shore RE; Okubo T
    Radiat Prot Dosimetry; 2012 Oct; 151(4):674-6. PubMed ID: 22908358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved estimates of cancer site-specific risks for A-bomb survivors.
    Pawel D; Preston D; Pierce D; Cologne J
    Radiat Res; 2008 Jan; 169(1):87-98. PubMed ID: 18159958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological research on radiation-induced cancer in atomic bomb survivors.
    Ozasa K
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i112-i117. PubMed ID: 26976124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on the article "Analysis of the incidence of solid cancer among atomic bomb survivors using a two-stage model of carcinogenesis" by M. Kai, E. G. Luebeck and S. H. Moolgavkar (Radiat. Res. 148, 348-358, 1997).
    Sherman CD
    Radiat Res; 1998 Mar; 149(3):308-9. PubMed ID: 9496896
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan.
    FOLLEY JH; BORGES W; YAMAWAKI T
    Am J Med; 1952 Sep; 13(3):311-21. PubMed ID: 12985588
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on "Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb" by D.J. Brenner (Radiat. Res. 145, 501-507, 1996).
    Schmid E; Bauchinger M
    Radiat Res; 1996 Oct; 146(4):479-82. PubMed ID: 8927721
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Incidence of salivary gland tumors among atomic bomb survivors, 1950-1987. Evaluation of radiation-related risk" by Land et al. (Radiat. Res. 146, 28-36, 1996).
    Pogoda JM; Preston-Martin S
    Radiat Res; 1996 Sep; 146(3):356. PubMed ID: 8752317
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of atomic bomb survivors.
    Sakata R; Grant EJ; Ozasa K
    Maturitas; 2012 Jun; 72(2):99-103. PubMed ID: 22440534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation dose response estimation with emphasis on low dose range using restricted cubic splines: application to all solid cancer mortality data, 1950-2003, in atomic bomb survivors.
    Nakashima E
    Health Phys; 2015 Jul; 109(1):15-24. PubMed ID: 26011495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on the Japanese atomic bomb survivors of radiation received from the bombs.
    Cullings HM
    Health Phys; 2014 Feb; 106(2):281-93. PubMed ID: 24378504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between anthropometric factors, radiation exposure, and colon cancer incidence in the Life Span Study cohort of atomic bomb survivors.
    Semmens EO; Kopecky KJ; Grant E; Mathes RW; Nishi N; Sugiyama H; Moriwaki H; Sakata R; Soda M; Kasagi F; Yamada M; Fujiwara S; Akahoshi M; Davis S; Kodama K; Li CI
    Cancer Causes Control; 2013 Jan; 24(1):27-37. PubMed ID: 23085813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atomic bomb injuries among survivors in Hiroshima.
    REYNOLDS ML; LYNCH FX
    Public Health Rep (1896); 1955 Mar; 70(3):261-70. PubMed ID: 14357547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.